These observations are in line with other reports in which galectin-9 expression was inversely correlated with cancer progression and patient survival in a number of different cancer types, including skin cancer, liver cancer, and breast cancer [34]–[36]. This evidence concerns the gene LGALS9 and breast carcinoma.